Neonatal lupus syndromes

Israel Medical Association Journal

Volumn 2, Issue 3, 2000, Pages 228-231

  Cimaz, R ^a   Catelli, L ^a   Luzzana, C ^a   Panzeri, P ^a   Meroni, P ^a  

^a Dept of Pediatrics ^*  (Italy)

Author keywords

Autoimmunity; Congenital heart block; Neonatal lupus; SSA Ro; SSb La

Indexed keywords

CELL NUCLEUS ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; ISOPRENALINE; LIDOCAINE; SALBUTAMOL;

ADRENAL SUPPRESSION; ANEMIA; ARTIFICIAL HEART PACEMAKER; AUTOIMMUNITY; BRADYCARDIA; CONGENITAL HEART BLOCK; HEART ARRHYTHMIA; HEMATOLOGIC DISEASE; HUMAN; NEONATAL LUPUS SYNDROME; OLIGOHYDRAMNIOS; PATHOGENESIS; PROGNOSIS; QT INTERVAL; RASH; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0033839163     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study, with review of the literature
2. Neonatal lupus
3. Congenital heart block and neonatal lupus erythematosus: Prevention is the goal
4. Neonatal lupus erythematosus: A transplacentally acquired autoimmune disorder
5. Congenital complete heart block: A human model of passively acquired autoimmune injury
6. Neonatal lupus syndromes
7. Neonatal lupus syndromes
8. Congenital complete heart block: An international study of the natural history
9. Transient neonatal bradycardia without heart block associated with anti-Ro antibodies
10. Anti-Ro associated sinus bradycardia in newborns
11. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block
12. Cutaneous lupus erythematosus during the neonatal and childhood periods
13. Trombocytopenia in the neonatal lupus syndrome
14. Liver disease in neonatal lupus erythematosus
15. Neonatal lupus liver disease
16. Immune-mediated congenital heart block (CCHB): Identifying and counselling patients at risk for having children with CCHB
17. Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus
18. Autoantibodies of neonatal lupus erythematosus
19. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus
20. Autoantibodies of neonatal lupus erythematosus
21. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block
22. DNA typing of material HLA in congenital complete heart block. Comparison with systemic lupus erythematosus and primary Sjogren's syndrome
23. Role of HLA in congenital heart block: Susceptibility alleles in mothers
24. Role of HLA in congenital heart block: Susceptibility alleles in children
25. Anti-Ro/SSA antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies
26. Neonatal lupus erythematosus with cardiac involvement in offspring of mothers with experimental systemic lupus erythematosus
27. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts
28. Arrythmogenicity of IgG and anti-52 kD SSA/Ro affinity purified antibodies from mothers of children with congenital heart block
29. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model
30. Autoantibodies to native 60 kD Ro/SSA and denatured 52 kD Ro/SSA are concentrated in eluates from the heart of a child who died with complete congenital heart block
31. Monozygotic twins discordant for congenital complete heart block
32. Neonatal lupus erythematosus. Report of serological and immunogenetic studies in twins discordant for congenital heart block
33. Neonatal lupus and autoantibodies reactive with SSA/Ro-SSB/La
34. Isolated congenital complete atrioventricular block in adult life. A prospective study
35. Isolated congenital complete heart block. Longterm outcome of mothers, maternal antibody specificity and immunogenetic background
36. Autoantibody associated congenital heart block: Outcome in mothers and children
37. Long-term outcome of mothers of children with complete congenital heart block
38. Isolated congenital heart block: Long term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La
39. Isolated congenital complete heart block. Longterm outcome of children and immunogenetic study
40. Steroid therapy for hydrops associated with antibody-mediated congenital heart block
41. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus